DNAH8 and neoplasm: Similar anti-ATPase activity for SRF617 was observed on MOLP-8 tumor cells (IC50 of 0.1 μg/ml [0.7 nM]) and in PBMCs from whole blood (IC50 of 0.2 μg/ml [1.2 nM]) (Fig. 1F, 1G).